SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckins Mubadala-backed investment and potential Gulf expansion are driving discussion, with traders viewing the sovereign funds involvement as a sign of institutional support and a possible step toward broader international growth. That optimism is tempered by frustration over the stocks weak, range-bound trading and speculation about buybacks and a future U.S. relisting, for which no timeline is established.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrows selloff is drawing attention amid investor frustration with repeated revenue and guidance misses, management execution, and uncertainty over VEVYEs ability to turn prescription growth into revenue. Long-term bulls still see potential in the expanding ophthalmology portfolio, but skeptics say the company needs to rebuild credibility with consistent results.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ousters Rev8 lidar is drawing attention as partners integrate it into autonomous applications, including wildfire-response drones, aerial mapping, and driverless orchard equipmentsupporting the communitys broader growth thesis around robotics and infrastructure sensing. Traders are bullish on expanding real-world use cases, but some remain frustrated by volatile trading and question how quickly deployments can scale.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivaxs sharp pullback and the absence of a confirmed takeover dominate discussion, with traders split between expecting a Big Pharma bid and viewing the stock as potentially stalled while the company advances obefazimod toward an ulcerative-colitis filing and Crohns data. A French filing reportedly showing Helikon increased its stake also drew attention, but takeover speculation remains unconfirmed.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axons proposed $1 billion offering of zero-coupon convertible notes has fueled concern about potential dilution and contributed to a sharp selloff. Traders are split between viewing the financing as a shareholder risk and seeing it as low-cost growth capital, with the stocks volatile rebound drawing further attention.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

A DEA administrative-law pause in the broader cannabis rescheduling process, prompted by questions about federal review procedures, has driven debate and volatility in cannabis stocks. Traders disagree over whether the pause is a temporary procedural delay or a setback to Schedule III and related tax relief; some see Trulieves medical-cannabis exposure as cushioning the impact, while others note it sold off with the sector.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injectives RWA and institutional-finance expansionincluding tokenized assets and its SEC transfer-agent statusis drawing attention alongside discussion of buybacks and a proposed supply-squeeze change that could increase INJs deflation rate if approved. Bulls view these developments as support for a recovery, while skeptics point to the tokens prolonged weakness and question whether the adoption will translate into demand.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

A modest rebound in Chinese internet stocks has revived discussion of a possible oversold bounce and rotation into China tech, with traders pointing to support and bullish options activity. Others argue the ETF remains in a broader downtrend, citing China-market weakness, policy risks, and persistent underperformance; no single confirmed catalyst dominates.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflares strong earnings and raised outlook, alongside optimism about its AI-agent and cybersecurity infrastructure, are supporting a momentum and new-highs conversation. Bulls point to growth potential and analyst optimism, while skeptics argue the valuation is stretched and warn of a pullback.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

Hyperliquids fee-funded token buybacks and burns are a key bullish theme, with traders also focused on HYPEs recent rally and tests of record highs. Sentiment is divided between dip-buyers expecting the uptrend to continue and traders warning of a pullback amid token-supply concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Brief Japan: Nikon (7731 JP): New Defense Business Beyond the Write-Down and more

In this briefing: Nikon (7731 JP): New Defense Business Beyond the Write-Down GENOVA (9341 JP): Q3 FY03/26 flash update Punch Industry (6165 JP): Q3 FY03/26 flash update Soliton Systems Kk (3040 JP): Full-year FY12/25 flash update Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate 1. Nikon (7731 JP): New Defense Business Beyond the Write-Down The market has discounted and moved beyond Nikon's write-down of the value of its additive manufacturing subsidiary Nikon SLM Solutions. Orders for 3D metal printers for HII's Newport News naval shipyard signal a new growth opportunity for Nikon's Digital Manufacturing business. The investment in Trener Robotics is the next step in the development of Nikon's Digital Manufacturing business. 2. GENOVA (9341 JP): Q3 FY03/26 flash update Revenue increased by 4.2% YoY to JPY7.9bn, but gross profit declined by 21.1% YoY to JPY4.4bn. Medical Platform business faced challenges with flat page views and a decline in contract volume by 11.5% YoY. Smart Clinic business maintained contract volume with a slight increase in average contract unit price for NOMOCa Stand. 3.

Brief Equities Bottom-Up: Nikon (7731 JP): New Defense Business Beyond the Write-Down and more

Brief Japan: Punch Industry (6165 JP): Q3 FY03/26 flash update and more

In this briefing: Punch Industry (6165 JP): Q3 FY03/26 flash update Soliton Systems Kk (3040 JP): Full-year FY12/25 flash update Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate How Long the Time-Killing Tactics of Companies with Average Foreign Ownership Can Last? Appier (4180) 1. Punch Industry (6165 JP): Q3 FY03/26 flash update Revenue increased to JPY31.5bn (+3.9% YoY), with significant growth in China and declines in Japan. Operating profit rose to JPY1.6bn (+38.1% YoY), driven by revenue growth in China offsetting high costs. Impairment loss on goodwill at ASCe affected net income, which rose slightly to JPY635mn (+1.8% YoY). 2. Soliton Systems Kk (3040 JP): Full-year FY12/25 flash update FY12/25 revenue increased to JPY19.8bn (+6.2% YoY) with operating profit at JPY2.8bn (+39.2% YoY). Soliton forecasts FY12/26 revenue of JPY21.2bn (+7.3% YoY) and operating profit of JPY3.2bn (+10.8% YoY). Soliton plans to pay an annual dividend of JPY60.00 per share in FY12/26 (JPY54.00 in FY12/25). 3.

Brief Equities Bottom-Up: Punch Industry (6165 JP): Q3 FY03/26 flash update and more

In this briefing: Punch Industry (6165 JP): Q3 FY03/26 flash update Soliton Systems Kk (3040 JP): Full-year FY12/25 flash update Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate Sea Ltd (SE US): Shopee Trading at Trough Valuations Primer: Seamec Ltd (SEAM IN) - Feb 2026 1. Punch Industry (6165 JP): Q3 FY03/26 flash update Revenue increased to JPY31.5bn (+3.9% YoY), with significant growth in China and declines in Japan. Operating profit rose to JPY1.6bn (+38.1% YoY), driven by revenue growth in China offsetting high costs. Impairment loss on goodwill at ASCe affected net income, which rose slightly to JPY635mn (+1.8% YoY). 2. Soliton Systems Kk (3040 JP): Full-year FY12/25 flash update FY12/25 revenue increased to JPY19.8bn (+6.2% YoY) with operating profit at JPY2.8bn (+39.2% YoY). Soliton forecasts FY12/26 revenue of JPY21.2bn (+7.3% YoY) and operating profit of JPY3.2bn (+10.8% YoY). Soliton plans to pay an annual dividend of JPY60.00 per share in FY12/26 (JPY54.00 in FY12/25). 3. Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate Revenue for Q3 FY03/26 was JPY28.2bn, a 5.0% YoY decline, with operating profit rising 13.2% YoY.

Brief Japan: Soliton Systems Kk (3040 JP): Full-year FY12/25 flash update and more

In this briefing: Soliton Systems Kk (3040 JP): Full-year FY12/25 flash update Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate How Long the Time-Killing Tactics of Companies with Average Foreign Ownership Can Last? Appier (4180) Toyo Kanetsu K K (6369 JP): Q3 FY02/26 flash update 1. Soliton Systems Kk (3040 JP): Full-year FY12/25 flash update FY12/25 revenue increased to JPY19.8bn (+6.2% YoY) with operating profit at JPY2.8bn (+39.2% YoY). Soliton forecasts FY12/26 revenue of JPY21.2bn (+7.3% YoY) and operating profit of JPY3.2bn (+10.8% YoY). Soliton plans to pay an annual dividend of JPY60.00 per share in FY12/26 (JPY54.00 in FY12/25). 2. Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate Revenue for Q3 FY03/26 was JPY28.2bn, a 5.0% YoY decline, with operating profit rising 13.2% YoY. The company aims to enhance profitability and cash generation, focusing on gelatin, collagen peptide, and biomedical products. Revenue in Japan and North America declined, while India saw strong gelatin sales, boosting overall revenue. 3.

Brief Equities Bottom-Up: Soliton Systems Kk (3040 JP): Full-year FY12/25 flash update and more

In this briefing: Soliton Systems Kk (3040 JP): Full-year FY12/25 flash update Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate Sea Ltd (SE US): Shopee Trading at Trough Valuations Primer: Seamec Ltd (SEAM IN) - Feb 2026 Snap-on Incorporated’s Power Surge: Are New Product Launches Igniting a Critical Industry Comeback? 1. Soliton Systems Kk (3040 JP): Full-year FY12/25 flash update FY12/25 revenue increased to JPY19.8bn (+6.2% YoY) with operating profit at JPY2.8bn (+39.2% YoY). Soliton forecasts FY12/26 revenue of JPY21.2bn (+7.3% YoY) and operating profit of JPY3.2bn (+10.8% YoY). Soliton plans to pay an annual dividend of JPY60.00 per share in FY12/26 (JPY54.00 in FY12/25). 2. Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate Revenue for Q3 FY03/26 was JPY28.2bn, a 5.0% YoY decline, with operating profit rising 13.2% YoY. The company aims to enhance profitability and cash generation, focusing on gelatin, collagen peptide, and biomedical products. Revenue in Japan and North America declined, while India saw strong gelatin sales, boosting overall revenue. 3.

Brief Japan: Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate and more

In this briefing: Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate How Long the Time-Killing Tactics of Companies with Average Foreign Ownership Can Last? Appier (4180) Toyo Kanetsu K K (6369 JP): Q3 FY02/26 flash update Takara Bio (4974 JP): Takara Holdings (2531 JP)’s Tender Offer Is Light but Done 1. Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate Revenue for Q3 FY03/26 was JPY28.2bn, a 5.0% YoY decline, with operating profit rising 13.2% YoY. The company aims to enhance profitability and cash generation, focusing on gelatin, collagen peptide, and biomedical products. Revenue in Japan and North America declined, while India saw strong gelatin sales, boosting overall revenue. 2. How Long the Time-Killing Tactics of Companies with Average Foreign Ownership Can Last? Financial institutions' policy holdings of shares are expected to be addressed through share buybacks and subsequent cancellation by companies, with such share buybacks anticipated to continue beyond 2026. Overseas investors continued to net buyers in 2025, suggesting that the foreign ownership ratio of Japanese stocks is expected to remain at its current level.

Brief Equities Bottom-Up: Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate and more

In this briefing: Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate Sea Ltd (SE US): Shopee Trading at Trough Valuations Primer: Seamec Ltd (SEAM IN) - Feb 2026 Snap-on Incorporated’s Power Surge: Are New Product Launches Igniting a Critical Industry Comeback? XPO’s 30% Excess Door Capacity—The Hidden Operating Leverage Ready for a Freight Rebound! 1. Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate Revenue for Q3 FY03/26 was JPY28.2bn, a 5.0% YoY decline, with operating profit rising 13.2% YoY. The company aims to enhance profitability and cash generation, focusing on gelatin, collagen peptide, and biomedical products. Revenue in Japan and North America declined, while India saw strong gelatin sales, boosting overall revenue. 2. Sea Ltd (SE US): Shopee Trading at Trough Valuations Sea Ltd’s current margin pressure is investment-driven, not price-war driven, with logistics expansion and loyalty programs weighing short-term but strengthening long-term platform economics. Shopee monetization remains intact with scaling ads and stable take-rates, while Gaming and DFS provide stable earnings and growth support, reducing reliance on near-term e-commerce margin recovery.

Smartkarma | Nitta Gelatin (4977 JP): Q3 FY03/26 flash pdate

» Smartkarma / by Shared Research / Equity Bottom-Up Revenue for Q3 FY03/26 was JPY28.2bn, a 5.0% YoY decline, with operating profit rising 13.2% YoY. The company aims to enhance profitability and cash generation, focusing on gelatin, collagen peptide, and biomedical products. Revenue in Japan and North America declined, while India saw strong gelatin sales, boosting overall revenue. » Get straight to the source on Smartkarma.

Brief Equities Bottom-Up: Triodos Bank N.V. - What's New(s) in Amsterdam and more

In this briefing: Triodos Bank N.V. - What's New(s) in Amsterdam Nitta Gelatin (4977 JP): 1H FY03/26 flash pdate Vaalco Energy (NYSE: EGY): FY25 production guidance increased. CI on track Primer: ASICS Corp (7936 JP) - Nov 2025 Primer: Zepto (1936629D IN) - Nov 2025 1. Triodos Bank N.V. - What's New(s) in Amsterdam In this edition: • Philips | DRRT and Rubicon are the next ones to go to court • SBM Offshore | raises FY25 directional EBITDA guidance • PostNL | consortium of Business Post and Spotta has an appetite for the UPD • Triodos Bank | not liable towards DR holders represented by Stichting Triodos Tragedie • E-commerce & Logistics | EU plans to accelerate imposing levy on low-value parcels • Dutch politics | Hans Wijers and Sybrand Buma nominated to lead D66/CDA talks 2. Nitta Gelatin (4977 JP): 1H FY03/26 flash pdate In 1H FY03/26, revenue was JPY18.5bn (-6.3% YoY), operating profit JPY2.3bn (+9.3% YoY), net income JPY2.2bn (+170.0% YoY). Full-year FY03/26 forecast revised: net income JPY3.1bn (previous JPY2.1bn), dividend forecast raised to JPY30.0 total.

Nitta Gelatin India Ltd. engages in the manufacture and sale of gelatin, ossein, DCP, and collagen peptide. Its products include edible and pharmaceutical gelatin, wellnex collagen peptides, di calcium phosphate, chitosan, and other consumer products. It operates through the India and Outside India geographical segments. The company was founded on April 30, 1975 and is headquartered in Cochin, India.

Current Price	1,650.00
Prev Close	1,664.00
Open	1,623.00
Dividend Yield	0.89%
50-Day Moving Average	1,654.17
Beta	-0.28
Avg. Volume	4,408.52
PE Ratio	14.53

52-Week High	2,087.20
52-Week Low	938.00
Market Capitalization	14.98B
EPS (Annual)	107.11
Price to Book	2.93
Revenue Per Employee	12.09M

Feed

News

Sentiment

Fundamentals

Info

NITTAGELA.NSE Fundamentals